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Conclusions: Inhibition of IL-6 in IL-1β stimulated chondrocytes
resulted in reduced mRNA expression of pro-inﬂammatory cy-
tokines and cartilage-degrading enzymes. This indicates the
involvement of IL-6 in catabolic regulation in chondrocytes.
However, blocking IL-6 seemed to also affect the anabolic re-
sponses in chondroctyes. Decreased expression of key cartilage
molecules in response to anabolic treatments suggests a protec-
tive role for IL-6 in the chondrocyte. Our data provide evidence
suggesting that the cytokine, IL-6, could also have beneﬁcial
effects and could contribute to promoting cartilage repair pro-
cesses. Therefore, it will be crucial to monitor patients receiving
IL-6 blocking treatment closely for their joint health.
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Purpose: Obesity increases the risk of developing osteoarthri-
tis (OA) in both load-bearing and non-load-bearing joints. This
suggests that a systemic factor is involved, which is potentially
mediated by body fat itself. Obesity elevates circulating free fatty
acid (FA) levels, and OA is associated with increased intra-
articular FA content. Furthermore, adipose tissue is an active
endocrine organ that secretes numerous signaling molecules
(i.e., adipokines). One adipokine in particular, leptin, is associ-
ated with OA and acts synergistically with interleukin-1 (IL-1)
to increase inﬂammation in chondrocytes. We hypothesized that
leptin would function synergistically with IL-1 to increase gly-
cosaminoglycan (GAG) breakdown and nitric oxide production in
articular cartilage explants. We also investigated how elevated
fatty acids inﬂuence these effects.
Methods: Articular cartilage explants were harvested from the
femoral condyles of skeletally mature pigs. Explants were al-
lowed to stabilize in culture medium with 10% FBS for 72 h at
37 degrees C. Media were then replaced with either 0, 1, 10, or
100 ng/ml recombinant human leptin (BACHEM) with or without
the following treatments, for 48 hrs: a) 0.5 mM FA (1:1 oleic
and palmitic acids; SIGMA), b) 0.1 ng/ml recombinant porcine
IL-1alpha (R&D Systems), or c) a combination of 0.5 mM FA +
0.1 ng/ml IL-1alpha. Total sulfated (S)-GAG release into the me-
dia was measured using the 1,9-dimethylmethylene blue (DMB)
assay. To assess nitric oxide production, we measured the con-
centration of total nitrate and nitrite (termed “NOx”) in the media
using the Griess reaction assay. Results were divided by the wet
weight of the explant and normalized to the average control con-
dition value per joint (i.e., 0 ng/ml leptin and no treatment). Each
dose and treatment condition represents the average of 3-4 joints
and 4-5 explants per joint. Statistical signiﬁcance for treatment
effects at 0 ng/ml leptin were determined with student’s t-test.
Signiﬁcant leptin dose effects were determined using a single
factor ANOVA, with Dunnett’s post-hoc test.
Results: Leptin had no independent effect on S-GAG release
or NOx production in articular cartilage explants (p>0.05). FA
treatment increased S-GAG release by 70%, which was negated
by 10 and 100 ng/ml of leptin (Fig. 1A). IL-1 increased S-GAG
release by 3.8-fold, which was further increased to approximately
7-fold with leptin doses of 1, 10, or 100 ng/ml (Fig. 1A). When FA
and IL-1 treatments were combined, S-GAG release increased
markedly by 13.4-fold above the control value (Fig. 1A). FA
treatment had no effect on NOx production, although when
combined with IL-1, it decreased NOx production compared to
IL-1 alone (58-fold vs 80-fold, respectively) (Fig. 1B). Leptin did
not signiﬁcantly affect IL-1 or IL-1 + FA induced NOx production
(Fig. 1B).
Figure 1. Open symbols are control values. *p<0.05 versus control. #p<0.05
versus smaller leptin dose. Values = mean ± SEM.
Conclusions: Palmitic and oleic FA, when combined with IL-1,
have a signiﬁcant synergistic effect on S-GAG release, more
than doubling the independent combined effects of FA and IL-1.
Leptin also acted synergistically with IL-1 to increase S-GAG
release, consistent with previously reported pro-inﬂammatory
effects of leptin on chondrocyte activity, although our results
were independent of nitric oxide production. Surprisingly, though,
leptin reduced FA-induced S-GAG release, suggesting that leptin
is protective against the catabolic effects of a high-FA load.
Leptin may attenuate FA-induced catabolism by stimulating FA
oxidation and reducing intra-cellular FA levels.
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Purpose: OA cartilage explants spontaneously produce PGE2,
the predominant eicosanoid of cyclooxygenase pathway, which
signals via four G-protein-coupled receptors, EP1-EP4. The
present study investigates the role of PGE2 on aggrecan
metabolism in chondrocytes.
Methods: OA chondrocytes were isolated from patients under-
going knee replacement surgery. Proteoglycan synthesis was de-
termined using 35S incorporation. MMP-13, cytokines were es-
timated using ELISA kits (R&D systems). Induction of ADAMTS
was determined using TaqMan real time PCR and fold change
was calculated and normalized with GAPDH using 2 delta Ct
method.
Results: The expression of prostaglandin biosynthetic pathway
